AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2005
Jan 3, 2005
35134_dirs_2005-01-03_2a25a55d-4b15-4d84-8f04-44c605ddfb5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (coff)
CIK: 0000025743
Period of Report: 2004-12-31
Reporting Person: JENSEN GERALD L (Director, President, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Croff Enterprises, Inc. Common Stock | 246988 | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16